title: Frequency of uterine contractions and the risk of spontaneous preterm delivery.
abstract: BACKGROUND
  The measurement of the frequency of uterine contractions has not been useful for reducing the rate of preterm delivery in randomized trials. Nonetheless, ambulatory monitoring of contractions continues to be used in clinical practice.
  
  
  METHODS
  We assessed the frequency of uterine contractions as a predictor of the risk of spontaneous preterm delivery before 35 weeks of gestation. We enrolled women with singleton pregnancies between 22 and 24 weeks of gestation. The women used a contraction monitor at home to record contraction frequency twice daily on 2 or more days per week from enrollment to delivery or 37 weeks of gestation.
  
  
  RESULTS
  We obtained 34,908 hours of successful monitoring recordings from 306 women. Although more contractions were recorded from women who delivered before 35 weeks than from women who delivered at 35 weeks or later, we could identify no threshold frequency that effectively identified women who delivered preterm infants. The sensitivity and positive predictive value of a maximal hourly frequency of contractions of four or more between 4 p.m. and 3:59 a.m. were 9 percent and 25 percent, respectively, at 22 to 24 weeks and 28 percent and 23 percent at 27 to 28 weeks. Other proposed screening tests, such as digital and ultrasound evaluations of the cervix and assays for fetal fibronectin in cervicovaginal secretions, also had low sensitivity and positive predictive value for preterm labor.
  
  
  CONCLUSIONS
  Although the likelihood of preterm delivery increases with an increased frequency of uterine contractions, measurement of this frequency is not clinically useful for predicting preterm delivery.
authors.affiliation: Department of obstetrics and gynecology at Ohio State University, Columbus 43210-1228, USA.
authors.forename: Jay D
authors.initials: JD
authors.lastname: Iams
authors.forename: Roger B
authors.initials: RB
authors.lastname: Newman
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Thom
authors.forename: Robert L
authors.initials: RL
authors.lastname: Goldenberg
authors.forename: Eberhard
authors.initials: E
authors.lastname: Mueller-Heubach
authors.forename: Atef
authors.initials: A
authors.lastname: Moawad
authors.forename: Baha M
authors.initials: BM
authors.lastname: Sibai
authors.forename: Steve N
authors.initials: SN
authors.lastname: Caritis
authors.forename: Menachem
authors.initials: M
authors.lastname: Miodovnik
authors.forename: Richard H
authors.initials: RH
authors.lastname: Paul
authors.forename: Mitchell P
authors.initials: MP
authors.lastname: Dombrowski
authors.forename: Gary
authors.initials: G
authors.lastname: Thurnau
authors.forename: Donald
authors.initials: D
authors.lastname: McNellis
mesh_terms: D002584:Cervix Uteri / Q000033:anatomy & histology / Q000502:physiology; D005260:Female; D005353:Fibronectins / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D016015:Logistic Models; D015999:Multivariate Analysis; D007752:Obstetric Labor, Premature / Q000175:diagnosis*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D012372:ROC Curve; D012306:Risk; D012680:Sensitivity and Specificity; D014590:Uterine Contraction; D018590:Uterine Monitoring
chemical_list: D005353:Fibronectins